0000037785-17-000040.txt : 20170614 0000037785-17-000040.hdr.sgml : 20170614 20170614102037 ACCESSION NUMBER: 0000037785-17-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170614 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170614 DATE AS OF CHANGE: 20170614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FMC CORP CENTRAL INDEX KEY: 0000037785 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 940479804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02376 FILM NUMBER: 17910439 BUSINESS ADDRESS: STREET 1: 2929 WALNUT STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 215-299-6668 MAIL ADDRESS: STREET 1: 2929 WALNUT STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: FOOD MACHINERY & CHEMICAL CORP DATE OF NAME CHANGE: 19670706 FORMER COMPANY: FORMER CONFORMED NAME: BEAN SPRAY PUMP CO DATE OF NAME CHANGE: 19670706 8-K 1 fmc8khndiscontinuedrecasted.htm 8-K Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________________________
 FORM 8-K
_______________________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 14, 2017
__________________________________________________________________________
FMC CORPORATION
(Exact name of registrant as specified in its charter)
__________________________________________________________________________ 
Delaware
1-2376
94-0479804
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer
Identification No.)
 
 
 
2929 Walnut Street
Philadelphia, Pennsylvania
 
19104
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 215-299-6000
__________________________________________________________________________

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company
o
 
 
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act.
 
o
 


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act






Item 2.02 Results of Operations and Financial Condition.
As previously announced on Form 8-K filed on March 31, 2017, FMC Corporation (the "Company") issued a press release announcing that it had signed a definitive agreement with E.I. du Pont de Nemours and Company ("DuPont") to acquire a significant portion of DuPont’s Crop Protection business and research and development organization. Additionally, DuPont will acquire FMC Health and Nutrition, excluding its Omega-3 business, and receive $1.2 billion in cash, subject to customary adjustments and other terms and conditions set forth in the definitive agreement.  In March 2017, as a result of the expected transaction with DuPont, our FMC Health and Nutrition segment was classified as a discontinued operation.
Attached as Exhibit 99.1 are schedules presenting certain financial information of FMC Corporation after reclassifying our FMC Health and Nutrition segment to a discontinued operation for each quarterly period within our fiscal year ended December 31, 2016 as well as the full year fiscal years ended December 31, 2016 and 2015, respectively.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
FMC CORPORATION
(Registrant)
 
 
 
 
 
By:
/s/ PAUL W. GRAVES
 
 
Paul W. Graves
Executive Vice President and
Chief Financial Officer
Date: June 14, 2017





EXHIBIT INDEX



 EX-99.1 2 fmcex991hndiscontinuedreca.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1

Discontinued Operations Presentation - FMC Health and Nutrition
On March 31, 2017, we signed a definitive agreement to sell FMC Health and Nutrition, excluding its Omega-3 business, to DuPont and we expect the sale to be completed in the fourth quarter of 2017, subject to customary regulatory approvals and closing conditions. Additionally, as part of the strategic shift to exit the Health and Nutrition business, we are pursuing the sale of our Omega-3 business and believe it is probable it will be sold within one year.
We have concluded, as a result of the signing of the definitive agreement with DuPont and the pursuit of the Omega-3 sale, that FMC Health and Nutrition has met the criteria to be an asset held for sale and therefore will be presented as a discontinued operation in accordance with U.S. generally accepted accounting principles ("GAAP"). Accordingly, we have recasted the following financial schedules for each quarterly period within the fiscal year ended December 31, 2016 as well as the full year fiscal years ended December 31, 2016 and 2015, respectively, to present the FMC Health and Nutrition segment as a discontinued operation.

Recasted Financial Schedules:
FINANCIAL SCHEDULES
PAGE
RECASTED - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
RECASTED - RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
RECASTED - INDUSTRY SEGMENT DATA
RECASTED - CAPITAL EXPENDITURES, DEPRECIATION, AMORTIZATION AND RESEARCH AND DEVELOPMENT DATA BY SEGMENT



FMC CORPORATION
RECASTED - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in millions, except per share amounts)
 
2016
 
2015
 
Q1
 
Q2
 
Q3
 
Q4
 
FY
 
FY
Revenue
$
606.4

 
$
615.3

 
$
628.8

 
$
688.4

 
$
2,538.9

 
$
2,491.0

 
 
 
 
 
 
 
 
 
 
 
 
Costs of sales and services
390.4

 
379.9

 
414.2

 
423.2

 
1,607.7

 
1,690.6

 
 
 
 
 
 
 
 
 
 
 
 
Gross margin
216.0

 
235.4

 
214.6

 
265.2

 
931.2

 
800.4

 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative expenses
110.1

 
110.6

 
99.9

 
137.9

 
458.5

 
660.7

Research and development expenses
34.2

 
33.2

 
30.6

 
36.5

 
134.5

 
135.9

Restructuring and other charges (income)
9.5


9.1


14.1


62.3


95.0


150.3

Total costs and expenses
544.2

 
532.8

 
558.8

 
659.9

 
2,295.7

 
2,637.5

Income from continuing operations before equity in (earnings) loss of affiliates, interest expense, net and income taxes
62.2

 
82.5

 
70.0

 
28.5

 
243.2

 
(146.5
)
Equity in (earnings) of affiliates
—

 
—

 
(0.4
)
 
(0.1
)
 
(0.5
)
 
—

Interest expense, net
15.8


15.2


15.4


16.5


62.9


60.9

 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) from continuing operations before income taxes
46.4

 
67.3

 
55.0

 
12.1

 
180.8

 
(207.4
)
Provision for income taxes
20.4

 
20.5

 
6.5

 
2.7

 
50.1

 
5.2

Income (loss) from continuing operations
26.0

 
46.8

 
48.5

 
9.4

 
130.7

 
(212.6
)
Discontinued operations, net of income taxes
22.7


20.2


31.1


7.0


81.0


711.1

Net income
$
48.7

 
$
67.0

 
$
79.6

 
$
16.4

 
$
211.7

 
$
498.5

  Less: Net income (loss) attributable to noncontrolling interests
0.4

 
1.8

 
(0.1
)
 
0.5

 
2.6

 
9.5

Net income attributable to FMC stockholders
$
48.3

 
$
65.2


$
79.7


$
15.9


$
209.1


$
489.0

 
 
 
 
 
 
 
 
 
 
 
 
Amounts attributable to FMC stockholders:
 
 
 
 
 
 
 
 
 
 
 
  Income (loss) from continuing operations, net of income tax
$
25.6

 
$
45.0

 
$
48.9

 
$
8.9

 
$
128.4

 
$
(222.0
)
  Income from Discontinued operations, net of income tax
22.7

 
20.2

 
30.8

 
7.0

 
80.7

 
711.0

Net income (loss) attributable to FMC stockholders
$
48.3

 
$
65.2

 
$
79.7

 
$
15.9

 
$
209.1

 
$
489.0

Basic earnings (loss) per common share attributable to FMC stockholders:
 
 
 
 
 
 
 
 
 
 
 
  Continuing operations (1)
$
0.19

 
$
0.34

 
$
0.36

 
$
0.07

 
$
0.96

 
$
(1.66
)
  Discontinued operations (1)
0.17

 
0.15

 
0.23

 
0.05

 
0.60

 
5.32

  Basic earnings per common share (1)
$
0.36

 
$
0.49

 
$
0.59

 
$
0.12

 
$
1.56

 
$
3.66

Average number of shares outstanding used in basic earnings per share computations
133.8

 
133.9

 
134.0

 
133.9

 
133.9

 
133.7

Diluted earnings (loss) per common share attributable to FMC stockholders:
 
 
 
 
 
 
 
 
 
 
 
Continuing operations (1)
$
0.19

 
$
0.34

 
$
0.36

 
$
0.07

 
$
0.96

 
$
(1.66
)
  Discontinued operations (1)
0.17

 
0.15

 
0.23

 
0.05

 
0.60

 
5.32

  Diluted earnings per common share (1)
$
0.36

 
$
0.49

 
$
0.59

 
$
0.12

 
$
1.56

 
$
3.66

Average number of shares outstanding used in diluted earnings per share computations
134.3

 
134.6

 
134.7

 
134.8

 
134.5

 
133.7

(1)     The sum of quarterly earnings per common share may differ from the full year amounts due to rounding.


FMC CORPORATION
RECASTED - RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

RECASTED - RECONCILIATION OF NET INCOME ATTRIBUTABLE TO FMC STOCKHOLDERS (GAAP)
TO ADJUSTED AFTER-TAX EARNINGS FROM CONTINUING OPERATIONS,
ATTRIBUTABLE TO FMC STOCKHOLDERS (NON-GAAP)
(Unaudited, in millions, except per share amounts)

 
2016
 
2015
 
Q1
 
Q2
 
Q3
 
Q4
 
FY
 
FY
Net income attributable to FMC stockholders (GAAP)
$
48.3

 
$
65.2

 
$
79.7

 
$
15.9

 
$
209.1

 
$
489.0

Corporate special charges (income):
 
 
 
 
 
 
 
 
 
 
 
Restructuring and other charges (income)
9.5


9.1


14.1


62.3


95.0


150.3

Non-operating pension and postretirement charges
1.1


1.2


0.2


20.9


23.4


29.8

Acquisition-related charges
7.4


5.0


4.4


6.6


23.4


290.3

Income tax expense (benefit) on Corporate special charges (income)
(5.2
)
 
(4.5
)
 
(5.0
)
 
(30.2
)
 
(44.9
)
 
(137.8
)
Discontinued operations attributable to FMC stockholders, net of income taxes (1)
(22.7
)
 
(20.2
)
 
(30.8
)
 
(7.0
)
 
(80.7
)
 
(711.0
)
Non-GAAP tax adjustments
9.6

 
6.5

 
(3.9
)
 
20.2

 
32.4

 
94.7

 
 
 
 
 
 
 
 
 
 
 
 
Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP) (2)
$
48.0

 
$
62.3

 
$
58.7

 
$
88.7

 
$
257.7

 
$
205.3

 
 
 
 
 
 
 
 
 
 
 
 
Diluted earnings per common share (GAAP) (3)
$
0.36

 
$
0.49

 
$
0.59

 
$
0.12

 
$
1.56

 
$
3.66

Corporate special charges (income) per diluted share, before tax:
 
 
 
 
 
 
 
 
 
 
 
Restructuring and other charges (income)
0.07

 
0.06

 
0.10

 
0.46

 
0.71

 
1.12

Non-operating pension and postretirement charges
0.01

 
0.01

 
—

 
0.16

 
0.17

 
0.22

Acquisition-related charges
0.06

 
0.04

 
0.03

 
0.05

 
0.17

 
2.16

Income tax expense (benefit) on Corporate special charges (income), per diluted share
(0.04
)
 
(0.03
)
 
(0.04
)
 
(0.23
)
 
(0.33
)
 
(1.02
)
Discontinued operations attributable to FMC stockholders, net of income taxes per diluted share
(0.17
)
 
(0.15
)
 
(0.22
)
 
(0.05
)
 
(0.60
)
 
(5.32
)
Non-GAAP tax adjustments per diluted share
0.07

 
0.04

 
(0.02
)
 
0.15

 
0.24

 
0.71

 
 
 
 
 
 
 
 
 
 
 
 
Diluted adjusted after-tax earnings from continuing operations per share, attributable to FMC stockholders (Non-GAAP) (3)
$
0.36

 
$
0.46

 
$
0.44

 
$
0.66

 
$
1.92

 
$
1.53

 
 
 
 
 
 
 
 
 
 
 
 
Average number of shares outstanding used in diluted adjusted after-tax earnings from continuing operations per share computations (4)
134.3

 
134.6

 
134.7

 
134.8

 
134.5

 
134.4

(1)
Discontinued operations, net of income taxes for 2015 includes an after-tax gain of approximately $702 million resulting from the divestiture of FMC Alkali Chemicals Division.
(2)
The Company believes that the Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders”, and its presentation on a per share basis, provides useful information about the Company’s operating results to investors and securities analysts. Adjusted earnings excludes the effects of corporate special charges, tax-related adjustments and the results of our discontinued operations. The Company also believes that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of its underlying businesses from period to period.
(3)
The sum of quarterly earnings per common share may differ from the full year amounts due to rounding.
(4)
The average number of shares outstanding used in the twelve months ended December 31, 2015 diluted adjusted after-tax earnings from continuing operations per share computation (Non-GAAP) includes 0.7 million diluted shares. The number of shares differs from the average number of shares outstanding used in diluted earnings per share computations (GAAP) as we had a net loss from continuing operations attributable to FMC stockholders.



FMC CORPORATION
RECASTED - RECONCILIATION OF NET INCOME (GAAP) TO ADJUSTED EARNINGS FROM CONTINUING OPERATIONS,
BEFORE INTEREST AND INCOME TAXES (NON-GAAP)
(Unaudited, in millions)
 
2016
 
2015
 
Q1
 
Q2
 
Q3
 
Q4
 
FY
 
FY
Net income (GAAP)
$
48.7

 
$
67.0

 
$
79.6

 
$
16.4

 
$
211.7

 
$
498.5

Restructuring and other charges (income)
9.5

 
9.1

 
14.1

 
62.3

 
95.0

 
150.3

Non-operating pension and postretirement charges
1.1

 
1.2

 
0.2

 
20.9

 
23.4

 
29.8

Acquisition-related charges
7.4

 
5.0

 
4.4

 
6.6

 
23.4

 
290.3

Discontinued operations, net of income taxes
(22.7
)
 
(20.2
)
 
(31.1
)
 
(7.0
)
 
(81.0
)
 
(711.1
)
Interest expense, net
15.8

 
15.2

 
15.4

 
16.5

 
62.9

 
60.9

Provision for income taxes
20.4

 
20.5

 
6.5

 
2.7

 
50.1

 
5.2

Adjusted earnings from continuing operations, before interest, income taxes and noncontrolling interests (Non-GAAP)
$
80.2

 
$
97.8

 
$
89.1

 
$
118.4

 
$
385.5

 
$
323.9



FMC CORPORATION
RECASTED - INDUSTRY SEGMENT DATA
(Unaudited, in millions)
 
2016
 
2015
 
Q1
 
Q2
 
Q3
 
Q4
 
FY
 
FY
Revenue
 
 
 
 
 
 
 
 
 
 
 
FMC Agricultural Solutions
$
546.1

 
$
552.0

 
$
558.9

 
$
617.8

 
$
2,274.8

 
$
2,252.9

FMC Lithium
60.3

 
63.3

 
69.9

 
70.6

 
264.1

 
238.1

Total
$
606.4

 
$
615.3

 
$
628.8

 
$
688.4

 
$
2,538.9

 
$
2,491.0

Income from continuing operations before income taxes
 
 
 
 
 
 
 
 
 
 
 
FMC Agricultural Solutions
82.0

 
100.7

 
90.1

 
127.1

 
399.9

 
363.9

FMC Lithium
14.9

 
16.5

 
17.5

 
21.3

 
70.2

 
23.0

Segment operating profit (1)
96.9

 
117.2

 
107.6

 
148.4

 
470.1

 
386.9

Corporate and other
(16.7
)
 
(19.4
)
 
(18.5
)
 
(30.0
)
 
(84.6
)
 
(63.0
)
Adjusted earnings from continuing operations, before interest, income taxes and noncontrolling interests (Non-GAAP)
$
80.2

 
$
97.8

 
$
89.1

 
$
118.4

 
$
385.5

 
$
323.9

 
 
 
 
 
 
 
 
 
 
 
 
Interest expense, net
(15.8
)
 
(15.2
)
 
(15.4
)
 
(16.5
)
 
(62.9
)
 
(60.9
)
Corporate special (charges) income:
 
 
 
 
 
 
 
 


 
 
Restructuring and other (charges) income
(9.5
)
 
(9.1
)
 
(14.1
)
 
(62.3
)
 
(95.0
)
 
(150.3
)
Non-operating pension and postretirement charges
(1.1
)
 
(1.2
)
 
(0.2
)
 
(20.9
)
 
(23.4
)
 
(29.8
)
Acquisition related charges
(7.4
)
 
(5.0
)
 
(4.4
)
 
(6.6
)
 
(23.4
)
 
(290.3
)
Provision for income taxes
(20.4
)
 
(20.5
)
 
(6.5
)
 
(2.7
)
 
(50.1
)
 
(5.2
)
Discontinued operations, net of income taxes
22.7

 
20.2

 
31.1

 
7.0

 
81.0

 
711.1

Net income attributable to noncontrolling interests
(0.4
)
 
(1.8
)
 
0.1

 
(0.5
)
 
(2.6
)
 
(9.5
)
Net income attributable to FMC stockholders
$
48.3

 
$
65.2

 
$
79.7

 
$
15.9

 
$
209.1

 
$
489.0

(1)     Referred to as Segment Earnings.


FMC CORPORATION
RECASTED - CAPITAL EXPENDITURES, DEPRECIATION, AMORTIZATION AND RESEARCH AND DEVELOPMENT DATA BY SEGMENT
(Unaudited, in millions)

 
Year Ended December 31
(in Millions)
Capital Expenditures
 
Depreciation and Amortization
 
Research and Development Expense
2016
 
2015
 
2016
 
2015
 
2016
 
2015
FMC Agricultural Solutions
$
23.1

 
$
29.2

 
$
80.8

 
$
60.5

 
$
131.4

 
$
132.4

FMC Lithium
24.4

 
17.4

 
14.8

 
12.2

 
3.1

 
3.5

Corporate
43.7

 
6.8

 
5.0

 
4.1

 
—

 
—

Total
$
91.2

 
$
53.4

 
$
100.6

 
$
76.8

 
$
134.5

 
$
135.9